TargTex is developing localized therapies for hard-to-treat CNS tumors.

TargTex is determined to find novel correlations between small molecules and targets that are overexpressed in oncological indication. Our lead product is being developed as an adjunct to surgery taking advantage its selectivity towards an unexplored target in Glioblastoma.

Our Mission

TargTex is developing a concerted approach, aligning scientists, physicians and patients to advance an innovative therapy to treat a daunting disease, giving a chance to Glioblastoma patients to live instead of surviving.

Latest News

News / Events / Awards / Publications